【正】 Hubei Biocause Pharmaceutical Co.,Ltd. (Biocause,SZ:000627)announced on October 27th to invest RMB302 million in buildinga new propylene project.The prop
The Dow Chemical Company and theShenhua Group announced November3rd that they have taken another importantstep forward by submitting ProjectApplication Report
Shaanxi Beiyuan Chemical Industry Group Co Ltd announced that its 500 000 t/apolyvinyl chloride unit outlet qualified product on November 10th,representingsucc